Abstract
The mode of action of α-methyldopa in depleting dopamine (DA) levels in the striatum was studied. After the administration of α-methyldopa, the maximum accumulation of α-methyldopamine (α-MDA) occurred at 4 hours, the time of the maximal reduction in DA concentration. 6-Hydroxydopamine pretreatment markedly reduced the accumulation of α-MDA suggesting that this accumulation mainly occurs in DA-containing neurons. After α-methyldopa administration, the concentrations of DA and its metabolites dihydroxyphenylacetic acid and homovanillic acid declined between 1 and 4 hours and then began to recover. Pargyline, administered 1 hour after α-methyldopa, prevented the further decline in DA suggesting that the decrease in DA requires the deamination of DA by monoamine oxidase. α-Methyldopa pretreatment also decreased the amount of DA that accumulated 10 minutes after pargyline. The inhibitory effect of pargyline on monoamine oxidase activity was the same in both the α-methyldopa-treated and control groups. α-Methyldopa treatment reduced the accumulation of 3H-DA and 3H-metabolites in the striatum 10 minutes after the intraventricular injection of 3H-tyrosine. This effect is probably not due to a difference in the specific activity of tyrosine in tissue. These observations suggest that the decrease in the striatal DA concentration after α-methyldopa administration is mainly due to a decrease in the rate of DA synthesis.
Footnotes
- Received August 25, 1973.
- Accepted January 4, 1974.
- © 1974 by The Williams & Wilkins Co.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|